iNova Pharmaceuticals, a company that markets and distributes a wide range of over-the-counter and prescription medicines in Australasia, Asia and Africa, has recently been recognised as one of the best places to work organisations in 2021. iNova achieved outstanding results in a number of assessment areas, and remains committed to using the feedback to continue fostering a culture where all employees can meaningfully contribute and reach their potential.
iNova Pharmaceuticals, a company that markets and distributes a wide range of over-the-counter and prescription medicines in Australasia, Asia and Africa, has recently been recognised as one of the best places to work organisations in 2021. iNova achieved outstanding results in a number of assessment areas, and remains committed to using the feedback to continue fostering a culture where all employees can meaningfully contribute and reach their potential.
With no idea she was even pregnant and her family on the other side of the country, Kate was in despair and felt no connection to the healthy baby boy that nurses held out to her.
Fertility Show Africa (FSA) – which took place in Gauteng at the weekend – was a resounding success, with a capacity crowd of more than 1700 people visiting this, the first fertility show to be held on the African continent.
Probiotec sells brand assets to iNova Pharmaceuticals
Pretoria - Every year an estimated 7.9 million children - 6% of total births worldwide - are born with a serious birth defect.
Pretoria - Every year an estimated 7.9 million children - 6% of total births worldwide - are born with a serious birth defect. any catalysts for a price change.
SINGAPORE, July 26, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that Andrew Howden has been elected as non-executive Chairman of the Board. Dr Carl Firth, who has held the positions of Chairman and CEO since founding the company in 2010, will continue to serve as CEO and as a Director. This planned separation of the Chairman and CEO roles was conducted to align to best corporate governance practices.